Biodesix Inc
(NASDAQ:BDSX)
$2.435
0.015[0.62%]
Last update: 1:01PM (Delayed 15-Minutes)
Get Real Time Here
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Biodesix Stock (NASDAQ:BDSX), Quotes and News Summary

Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.370 - 2.45052 Wk Range0.955 - 4.420Open / Close2.440 / -Float / Outstanding61.365M / 76.496M
Vol / Avg.32.023K / 186.172KMkt Cap186.267MP/E-50d Avg. Price1.870
Div / Yield (Forward)- / -%Payout Ratio-Total Float61.365MEPS-1.710
InvestorsObserver - Dec 30, 2022, 12:19PM
InvestorsObserver - Dec 2, 2022, 6:05AM
InvestorsObserver - Nov 22, 2022, 11:08AM
InvestorsObserver - Nov 17, 2022, 10:34AM
Seeking Alpha - Nov 17, 2022, 3:53AM
Seeking Alpha - Nov 16, 2022, 4:17PM
InvestorsObserver - Oct 18, 2022, 1:30PM
Seeking Alpha - Oct 18, 2022, 9:55AM
Seeking Alpha - Oct 11, 2022, 7:09AM
InvestorsObserver - Sep 9, 2022, 10:46AM
InvestorsObserver - Aug 24, 2022, 6:45AM
InvestorsObserver - Aug 1, 2022, 1:13PM
Seeking Alpha - Jul 15, 2022, 3:58PM
Sector: Health Care.Industry: Health Care Providers & Services
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-13
REV
Q3 2022Est.ActualSurprise
EPS-0.330-0.340 -0.0100
REV10.170M11.107M937.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biodesix (BDSX) stock?

A

You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biodesix (BDSX) stock?

A

The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biodesix (BDSX)?

A

The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.

Q

Does Biodesix (BDSX) pay a dividend?

A

There are no upcoming dividends for Biodesix.

Q

When is Biodesix (NASDAQ:BDSX) reporting earnings?

A

Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.

Q

Is Biodesix (BDSX) going to split?

A

There is no upcoming split for Biodesix.

Q

What sector and industry does Biodesix (BDSX) operate in?

A

Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.